Melphalan cas: 148-82-3

CAS NO: 148-82-3
Chemical Name: Melphalan
Molecular Formula: C13H18Cl2N2O2
Formula Weight: 305.2
CAS Number: 148-82-3
Description Review
Description
Melphalan is a chemotherapy medication that has been instrumental in the treatment of various types of cancer. As a potent drug, it has been the subject of numerous studies and has been widely used in the medical field for its efficacy in combating cancerous cells.

Top Ten Keywords from Google and Synonyms:
1. Melphalan
2. API
3. DNA alkylating agent
4. Antineoplastic
5. Alkylating
6. L-PAM
7. Cytotoxic
8. Antitumor activity
9. 4-[Bis(2-Chloroethyl)amino]-L-phenylalanine
10. Nitrogen Mustards
Competitive Products:
While Melphalan stands out in its class, there are other chemotherapy drugs that also fall under the category of alkylating agents. These include Cyclophosphamide, Ifosfamide, and Chlorambucil. Each of these drugs has its own set of indications, mechanisms of action, and side effects, but they all work by interfering with DNA replication in cancer cells.
Health Benefits:
Melphalan's primary benefit lies in its ability to treat and manage certain types of cancer. It has shown significant results in treating multiple myeloma and ovarian cancer. By stopping the growth and division of cancer cells, it helps in reducing tumor size and preventing the spread of cancer.
Potential Effects:
The potential effects of Melphalan are vast. It not only targets cancer cells but can also affect normal cells, leading to various side effects. However, its primary effect is to halt the replication of DNA in cancerous cells, thereby inhibiting their growth and spread.
Product Mechanism:
Melphalan works by alkylating the DNA molecule. This alkylation can cause DNA strands to cross-link, which prevents the DNA from replicating and the cell from dividing. This mechanism is what makes Melphalan effective against rapidly dividing cancer cells.
Safety:
Safety is paramount when using Melphalan. Patients should be under the care of experienced healthcare professionals. Regular monitoring is essential to check for any adverse reactions or complications.

Side Effects:
Like many chemotherapy drugs, Melphalan can cause side effects. Some common ones include nausea, vomiting, mouth sores, and hair loss. A more severe side effect is myelosuppression, which can lead to a decreased production of blood cells.
Dosing Information:
The dosing regimen for Melphalan varies depending on the type and stage of cancer, as well as the patient's overall health. It can be administered orally or via injection. It's crucial to follow the prescribed dose and schedule for optimal results.
Contraindication:
Patients with known hypersensitivity to Melphalan or any of its components should avoid this drug. It's also contraindicated in patients with severe bone marrow suppression.
Conclusion:
Melphalan has proven to be a vital tool in the fight against cancer. Its mechanism of action, combined with its efficacy, makes it a preferred choice for treating certain types of cancer. However, like all medications, it comes with its set of challenges, including potential side effects. It's essential for patients and healthcare providers to work closely together to ensure the safe and effective use of this potent drug.
Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code